ARCHIVES

Protocol Amendments Required For 98 NCI-Sponsored Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

June 26, 2009

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

In Brief: Oncology Nursing Society Names Board Of Directors

May 16, 2014

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

July 20, 2012